Type 1 diabetes in pregnancy: degludec vs. detemir

被引：0
|
作者：
不详
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2023年 / 18卷 / 03期
关键词：
D O I：
10.1055/a-1945-2027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In der Schwangerschaft werden Frauen mit Typ-1-Diabetes haufig mit Insulin detemir behandelt. Der Blutzuckerspiegel kann damit gut reguliert werden, ohne dass ein erhohtes Risiko fur Hypoglykamien oder Schwangerschaftskomplikationen besteht. Das neuere Insulin degludec soll ein noch besseres Wirkprofil haben als andere Insulinanaloga und ist seit kurzem auch fur Schwangere zugelassen.
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] Maternal efficacy, safety, and pregnancy outcomes with degludec vs detemir in the treatment of pregnant women with type 1 diabetes: an international, multicentre, randomised trial
    Mathiesen, E. R.
    Corcoy, R.
    Dunne, F.
    Ekelund, M.
    Feig, D. S.
    Hod, M.
    Jia, T.
    Kalyanam, B.
    Kar, S.
    Kautzky-Willer, A.
    Damm, P.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 11 - 11
  • [2] Cardiovascular Events in Type 2 Diabetes: Insulin Degludec vs. Glargine
    Lichert, Frank
    DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (06) : 433 - 433
  • [3] Comparison of Efficacy of Detemir and Degludec Insulin in the Management of Children and Adolescents with Type 1 Diabetes
    Zabeen, Bedowra
    Ahmed, Bulbul
    Islam, Nasreen
    Tayyeb, Samin
    Nahar, Jebun
    Azad, Kishwar
    JOURNAL OF DIABETOLOGY, 2022, 13 (01) : 62 - 66
  • [4] Cardiovascular Events in Type-2-Diabetes: Insulin Degludec vs. Glargine
    Lichert, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1642 - +
  • [5] EXPLORING THE WEIGHT-NEUTRAL EFFECTS OF INSULIN DETEMIR VS. INSULIN GLARGINE IN TYPE 1 DIABETES
    Mitchell, S.
    Burge, M. R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 242 - 242
  • [6] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Yoshiki Kusunoki
    Tomoyuki Katsuno
    Kana Miyakoshi
    Takashi Ikawa
    Rie Nakae
    Fumihiro Ochi
    Masaru Tokuda
    Takafumi Akagami
    Kazuki Murai
    Masayuki Miuchi
    Tomoya Hamaguchi
    Jun-ichiro Miyagawa
    Mitsuyoshi Namba
    Diabetes Therapy, 2013, 4 : 461 - 472
  • [7] Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
    Kusunoki, Yoshiki
    Katsuno, Tomoyuki
    Miyakoshi, Kana
    Ikawa, Takashi
    Nakae, Rie
    Ochi, Fumihiro
    Tokuda, Masaru
    Akagami, Takafumi
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    DIABETES THERAPY, 2013, 4 (02) : 461 - 472
  • [8] Pregnancy outcomes in women with type 1 diabetes using insulin degludec
    Ringholm, Lene
    Do, Nicoline Callesen
    Damm, Peter
    Mathiesen, Elisabeth Reinhardt
    ACTA DIABETOLOGICA, 2022, 59 (05) : 721 - 727
  • [9] Pregnancy outcomes in women with type 1 diabetes using insulin degludec
    Lene Ringholm
    Nicoline Callesen Do
    Peter Damm
    Elisabeth Reinhardt Mathiesen
    Acta Diabetologica, 2022, 59 : 721 - 727
  • [10] Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial
    Davies, M.
    Sasaki, T.
    Gross, J. L.
    Bantwal, G.
    Ono, Y.
    Nishida, T.
    Tojjar, D.
    Seino, H.
    DIABETES OBESITY & METABOLISM, 2016, 18 (01): : 96 - 99
12345